- Filed
- Mar 19, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Mar 12, 2025 | 547.6M sh |
| Short Term Debt | Q3 2025 · Feb 23, 2025 | $406.7M |
| Short Term Debt | Q3 2025 · May 26, 2024 | $11.8M |
| Cash And Equivalents | Q3 2025 · Feb 23, 2025 | $521.3M |
| Cash And Equivalents | Q3 2025 · May 26, 2024 | $418M |
| Stockholders Equity | Q3 2025 · Feb 23, 2025 | $9.26B |
| Stockholders Equity | Q3 2025 · May 26, 2024 | $9.4B |
| Current Liabilities | Q3 2025 · Feb 23, 2025 | $7.88B |
| Current Liabilities | Q3 2025 · May 26, 2024 | $7.03B |
| Total Liabilities | Q3 2025 · Feb 23, 2025 | $23.19B |
| Total Liabilities | Q3 2025 · May 26, 2024 | $21.82B |
| Current Assets | Q3 2025 · Feb 23, 2025 | $5.26B |
| Current Assets | Q3 2025 · May 26, 2024 | $4.58B |
| Total Assets | Q3 2025 · Feb 23, 2025 | $32.71B |
| Total Assets | Q3 2025 · May 26, 2024 | $31.47B |
| Shares Diluted | Q3 2025 · Feb 25, 2024 | 572.8M sh |
| Shares Diluted | Q3 2025 · Feb 25, 2024 | 582.5M sh |
| Stock Repurchased | Q3 2025 · Feb 25, 2024 | $1.6B |
| Capex | Q3 2025 · Feb 25, 2024 | $485.6M |
| Operating Cash Flow | Q3 2025 · Feb 25, 2024 | $2.44B |
| Eps Diluted | Q3 2025 · Feb 25, 2024 | $1.17 |
| Eps Diluted | Q3 2025 · Feb 25, 2024 | $3.33 |
| Eps Basic | Q3 2025 · Feb 25, 2024 | $1.18 |
| Eps Basic | Q3 2025 · Feb 25, 2024 | $3.35 |
| Sga Expense | Q3 2025 · Feb 25, 2024 | $790.9M |
| Sga Expense | Q3 2025 · Feb 25, 2024 | $2.46B |
| Net Income | Q3 2025 · Feb 25, 2024 | $670.1M |
| Net Income | Q3 2025 · Feb 25, 2024 | $1.94B |
| Operating Income | Q3 2025 · Feb 25, 2024 | $910.7M |
| Operating Income | Q3 2025 · Feb 25, 2024 | $2.65B |
| Cost Of Revenue | Q3 2025 · Feb 25, 2024 | $3.39B |
| Cost Of Revenue | Q3 2025 · Feb 25, 2024 | $9.9B |
| Revenue | Q3 2025 · Feb 25, 2024 | $5.1B |
| Revenue | Q3 2025 · Feb 25, 2024 | $15.14B |